1. Analyst View
2. Research Overview
3. Industry Overview
3.1 Worldwide Therapeutic Segmentation in the Pharmaceutical Market
3.2 Worldwide Pharmaceutical Market Segmentation by Region
3.3 Worldwide Expenditure on Pharmaceutical Drugs
3.4 Worldwide Emerging Markets in Pharmaceutical Industry
4. Industry Performance
4.1 By Vendors
4.2 By Therapy Classes and Products
4.2.1 Therapy Classes
4.2.2 Product Classes
4.2.2.1 Biologics Market
4.2.2.2 Block Buster Products
4.2.2.3 Over the Counter Products (OTC)
4.3 By Geographical Spread
4.3.1 Asia-Pacific
4.3.1.1 India
4.3.1.2 China
4.3.1.3 Australia
4.3.1.4 Japan
4.3.1.5 Indonesia
4.3.1.6 Hong Kong
4.3.1.7 South Korea
4.3.2 Europe
4.3.2.1 United Kingdom
4.3.2.2 France
4.3.2.3 Germany
4.3.3 Latin America
4.3.3.1 Mexico
4.3.3.2 Brazil
4.3.3.3 Chile
4.3.4 North America
4.3.4.1 United States of America
4.3.4.2 Canada
4.3.5 Africa
4.3.5.1 South Africa
4.3.5.2 Egypt
4.3.5.3 Saudi Arabia
5. Key Driving Forces
6. Opportunities and Challenges
7. Future Outlook, 2010
8. Key Players
8.1 GlaxoSmithKline
8.2 AstraZeneca
8.3 Johnson & Johnson
8.4 Roche
8.5 Merck & Co.
8.6 Novartis
8.7 Wyeth
8.8 Bristol-Myers Squibb
8.9 Ranbaxy Laboratories Ltd.
.jpg)
